# Hepcidine and Iron Deficiency in Critically Ill Patients

> **NCT02276690** · NA · COMPLETED · sponsor: **University Hospital, Montpellier** · enrollment: 408 (actual)

## Conditions studied

- Anemia
- Critical Illness
- Hospitalized for 5 Days or More

## Interventions

- **BIOLOGICAL:** hepcidin
- **BIOLOGICAL:** ferritin and transferrin saturation

## Key facts

- **NCT ID:** NCT02276690
- **Lead sponsor:** University Hospital, Montpellier
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-08
- **Primary completion:** 2016-10-26
- **Final completion:** 2017-09
- **Target enrollment:** 408 (ACTUAL)
- **Last updated:** 2017-10-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02276690

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02276690, "Hepcidine and Iron Deficiency in Critically Ill Patients". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT02276690. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*